ifosfamide has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 19 studies
Excerpt | Relevance | Reference |
---|---|---|
"The purpose of this study is to evaluate the stem cell mobilization capacity, anti-tumor effect, and feasibility of ifosfamide/carboplatin/etoposide (ICE) for transplant-eligible patients with medulloblastoma." | 9.12 | Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma. ( Hongo, T; Nishizawa, S; Ohzeki, T; Okada, S; Sakaguchi, K; Suzuki, K, 2007) |
"Ten children with newly diagnosed medulloblastoma/primitive neuroectodermal tumor of the posterior fossa were treated with total surgical resection, radiation therapy, and ICE chemotherapy regimen with ifosfamide (900 mg/m2, days 1-5), cisplatin (20 mg/m2, days 1-5), and etoposide (60 mg/m2, days 1-5) every 4 weeks for eight cycles." | 7.69 | Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study. ( Abe, H; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M, 1996) |
"The purpose of this study is to evaluate the stem cell mobilization capacity, anti-tumor effect, and feasibility of ifosfamide/carboplatin/etoposide (ICE) for transplant-eligible patients with medulloblastoma." | 5.12 | Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma. ( Hongo, T; Nishizawa, S; Ohzeki, T; Okada, S; Sakaguchi, K; Suzuki, K, 2007) |
"Ten children with newly diagnosed medulloblastoma/primitive neuroectodermal tumor of the posterior fossa were treated with total surgical resection, radiation therapy, and ICE chemotherapy regimen with ifosfamide (900 mg/m2, days 1-5), cisplatin (20 mg/m2, days 1-5), and etoposide (60 mg/m2, days 1-5) every 4 weeks for eight cycles." | 3.69 | Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study. ( Abe, H; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M, 1996) |
"The present case, a CNS PNET, is suspected as a secondary brain tumor induced by radiation therapy previously used to treat a medulloblastoma, and it represents a rare late-onset complication of radiation therapy." | 2.50 | [CNS primitive neuroectodermal tumor suspected as a secondary recurrence after radiation therapy for medulloblastoma:a case report]. ( Endo, S; Kato, S; Koizumi, T; Sato, H; Shibuya, K, 2014) |
"Medulloblastomas are among the most frequently diagnosed pediatric solid tumors, and drug resistance remains as the principal cause of treatment failure." | 1.51 | Hypoxia increases chemoresistance in human medulloblastoma DAOY cells via hypoxia‑inducible factor 1α‑mediated downregulation of the CYP2B6, CYP3A4 and CYP3A5 enzymes and inhibition of cell proliferation. ( Aquino-Jarquín, G; Arias-Montaño, JA; Dávila-Borja, VM; Huerta-Yepez, S; Martínez-Fong, D; Rodríguez-Enríquez, S; Valencia-Cervantes, J, 2019) |
"The adverse effects of combination chemotherapy of ifosfamide, cisplatin, and etoposide (ICE) were evaluated in the treatment of various intracranial brain tumors." | 1.36 | [The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases]. ( Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Yamashita, Y, 2010) |
"Medulloblastoma is a common paediatric brain tumor." | 1.35 | [Frontal relapse of medulloblastoma. Causes and consequences (a case report)]. ( Besbes, M; Chaari, N; Ghorbel, I; Kochbati, L; Maalej, M, 2008) |
"Medulloblastomas are highly lethal tumors when they recur." | 1.33 | Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas. ( Abe, M; Imamura, J; Kida, Y; Tabuchi, K; Takagi, M; Tokumaru, S, 2006) |
"In large-scale pediatric chemo- and radiotherapy trials a proportion of patients as high as 10-15% is usually reported as having severe treatment related toxicity occasionally resulting in toxic death." | 1.32 | Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. ( Distel, L; Grabenbauer, G; Holter, W; Neubauer, S; Varon, R, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (26.32) | 18.2507 |
2000's | 8 (42.11) | 29.6817 |
2010's | 5 (26.32) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Nobre, L | 1 |
Zapotocky, M | 1 |
Khan, S | 1 |
Fukuoka, K | 1 |
Fonseca, A | 1 |
McKeown, T | 1 |
Sumerauer, D | 1 |
Vicha, A | 1 |
Grajkowska, WA | 1 |
Trubicka, J | 1 |
Li, KKW | 1 |
Ng, HK | 1 |
Massimi, L | 1 |
Lee, JY | 1 |
Kim, SK | 1 |
Zelcer, S | 1 |
Vasiljevic, A | 1 |
Faure-Conter, C | 1 |
Hauser, P | 1 |
Lach, B | 1 |
van Veelen-Vincent, ML | 1 |
French, PJ | 1 |
Van Meir, EG | 1 |
Weiss, WA | 1 |
Gupta, N | 1 |
Pollack, IF | 1 |
Hamilton, RL | 1 |
Nageswara Rao, AA | 1 |
Giannini, C | 1 |
Rubin, JB | 1 |
Moore, AS | 1 |
Chambless, LB | 1 |
Vibhakar, R | 1 |
Ra, YS | 1 |
Massimino, M | 1 |
McLendon, RE | 1 |
Wheeler, H | 1 |
Zollo, M | 1 |
Ferruci, V | 1 |
Kumabe, T | 3 |
Faria, CC | 1 |
Sterba, J | 1 |
Jung, S | 1 |
López-Aguilar, E | 1 |
Mora, J | 1 |
Carlotti, CG | 1 |
Olson, JM | 1 |
Leary, S | 1 |
Cain, J | 1 |
Krskova, L | 1 |
Zamecnik, J | 1 |
Hawkins, CE | 1 |
Tabori, U | 1 |
Huang, A | 1 |
Bartels, U | 1 |
Northcott, PA | 1 |
Taylor, MD | 1 |
Yip, S | 1 |
Hansford, JR | 1 |
Bouffet, E | 1 |
Ramaswamy, V | 1 |
Valencia-Cervantes, J | 1 |
Huerta-Yepez, S | 1 |
Aquino-Jarquín, G | 1 |
Rodríguez-Enríquez, S | 1 |
Martínez-Fong, D | 1 |
Arias-Montaño, JA | 1 |
Dávila-Borja, VM | 1 |
Clement, J | 1 |
Varlotto, J | 1 |
Rybka, W | 1 |
Frauenhoffer, E | 1 |
Drabick, JJ | 1 |
Sato, H | 1 |
Shibuya, K | 1 |
Koizumi, T | 1 |
Kato, S | 1 |
Endo, S | 1 |
Kochbati, L | 1 |
Ghorbel, I | 1 |
Chaari, N | 1 |
Besbes, M | 1 |
Maalej, M | 1 |
Yasuda, K | 1 |
Taguchi, H | 1 |
Sawamura, Y | 2 |
Ikeda, J | 2 |
Aoyama, H | 1 |
Fujieda, K | 1 |
Ishii, N | 2 |
Kashiwamura, M | 1 |
Iwasaki, Y | 1 |
Shirato, H | 2 |
Kanamori, M | 2 |
Saito, R | 2 |
Yamashita, Y | 2 |
Sonoda, Y | 2 |
Tominaga, T | 2 |
Watanabe, M | 1 |
Distel, L | 1 |
Neubauer, S | 1 |
Varon, R | 1 |
Holter, W | 1 |
Grabenbauer, G | 1 |
Razak, AR | 1 |
Nasser, Q | 1 |
Morris, P | 1 |
Alcutt, D | 1 |
Grogan, L | 1 |
Geyer, JR | 1 |
Sposto, R | 1 |
Jennings, M | 1 |
Boyett, JM | 1 |
Axtell, RA | 1 |
Breiger, D | 1 |
Broxson, E | 1 |
Donahue, B | 1 |
Finlay, JL | 1 |
Goldwein, JW | 1 |
Heier, LA | 1 |
Johnson, D | 1 |
Mazewski, C | 1 |
Miller, DC | 1 |
Packer, R | 1 |
Puccetti, D | 1 |
Radcliffe, J | 1 |
Tao, ML | 1 |
Shiminski-Maher, T | 1 |
Abe, M | 1 |
Tokumaru, S | 1 |
Tabuchi, K | 1 |
Kida, Y | 1 |
Takagi, M | 1 |
Imamura, J | 1 |
Okada, S | 1 |
Hongo, T | 1 |
Sakaguchi, K | 1 |
Suzuki, K | 1 |
Nishizawa, S | 1 |
Ohzeki, T | 1 |
Grabenbauer, GG | 1 |
Löhnert, C | 1 |
Erhardt, J | 1 |
Buchfelder, M | 1 |
Neubauer, U | 1 |
Beck, JD | 1 |
Reitz, S | 1 |
Seyer, H | 1 |
Thierauf, P | 1 |
Fietkau, R | 1 |
Kato, T | 1 |
Tada, M | 1 |
Abe, H | 1 |
Leo, E | 1 |
Schlegel, PG | 1 |
Lindemann, A | 1 |
Kaijser, GP | 1 |
Ter Riet, PG | 1 |
de Kraker, J | 1 |
Bult, A | 1 |
Beijnen, JH | 1 |
Underberg, WJ | 1 |
Urban, C | 1 |
Benesch, M | 1 |
Pakisch, B | 1 |
Lackner, H | 1 |
Kerbl, R | 1 |
Schwinger, W | 1 |
Oberbauer, R | 1 |
Noël, G | 1 |
Mazeron, JJ | 1 |
1 review available for ifosfamide and Arachnoidal Cerebellar Sarcoma, Circumscribed
Article | Year |
---|---|
[CNS primitive neuroectodermal tumor suspected as a secondary recurrence after radiation therapy for medulloblastoma:a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Cisplatin | 2014 |
4 trials available for ifosfamide and Arachnoidal Cerebellar Sarcoma, Circumscribed
Article | Year |
---|---|
Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Pr | 2008 |
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combin | 2005 |
Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chil | 2007 |
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Che | 1998 |
14 other studies available for ifosfamide and Arachnoidal Cerebellar Sarcoma, Circumscribed
Article | Year |
---|---|
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cerebellar Neoplasms; | 2020 |
Hypoxia increases chemoresistance in human medulloblastoma DAOY cells via hypoxia‑inducible factor 1α‑mediated downregulation of the CYP2B6, CYP3A4 and CYP3A5 enzymes and inhibition of cell proliferation.
Topics: Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Cyclophosphamide; Cytochro | 2019 |
Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Cerebellar Neoplasms; Cycloph | 2013 |
[Frontal relapse of medulloblastoma. Causes and consequences (a case report)].
Topics: Brain Neoplasms; Cerebellar Neoplasms; Child; Combined Modality Therapy; Humans; Ifosfamide; Male; M | 2008 |
[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, | 2010 |
Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single-institute experience and differences in efficacy for subgroups of medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Pr | 2011 |
Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome.
Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cyc | 2003 |
Medulloblastoma in two successive pregnancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; | 2005 |
Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherap | 2006 |
[Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Ne | 1993 |
Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Cerebellar Neopla | 1996 |
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplat | 1997 |
Determination of 4-hydroxyifosfamide in biological matrices by high-performance liquid chromatography.
Topics: Cerebellar Neoplasms; Child; Chromatography, High Pressure Liquid; Drug Stability; Humans; Ifosfamid | 1997 |
[Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of German prospective randomised trial HIT'91].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; | 2001 |